(Q38088893)

28 August 2017

Crosstalk between oxygen- and nitric oxide-dependent signaling pathways in angiogenesis (English)

1 reference

28 August 2017

1 reference

Peter Fraisl

1

1 reference

PubMed ID

23485765

28 August 2017

language of work or name

English

0 references

publication date

26 February 2013

1 reference

Experimental Cell Research

28 August 2017

1 reference

28 August 2017

319

1 reference

28 August 2017

9

1 reference

28 August 2017

1331-1339

1 reference

Molecular mechanisms and clinical applications of angiogenesis

28 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Oxygen sensors and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

The biology of VEGF and its receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Basic and therapeutic aspects of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Angiogenesis: a team effort coordinated by notch.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Regulation of angiogenesis by oxygen and metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

PHD3-dependent hydroxylation of HCLK2 promotes the DNA damage response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

The role of NF-kappaB in hypoxia-induced gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Mitochondrial reactive oxygen species regulate hypoxic signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Oxygen-sensing under the influence of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Gene-Targeting of Phd2 Improves Tumor Response to Chemotherapy and Prevents Side-Toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Sprouty2 downregulates angiogenesis during mouse skin wound healing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Regulation of cellular levels of Sprouty2 protein by prolyl hydroxylase domain and von Hippel-Lindau proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

The asparaginyl hydroxylase factor inhibiting HIF-1alpha is an essential regulator of metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Hypoxia-induced gene expression occurs solely through the action of hypoxia-inducible factor 1alpha (HIF-1alpha): role of cytoplasmic trapping of HIF-2alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Hypoxia-inducible transcription factor-2alpha in endothelial cells regulates tumor neovascularization through activation of ephrin A1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

HIF-2alpha specifically activates the VE-cadherin promoter independently of hypoxia and in synergy with Ets-1 through two essential ETS-binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Endothelial deletion of hypoxia-inducible factor-2alpha (HIF-2alpha) alters vascular function and tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Endothelial HIF-2α regulates murine pathological angiogenesis and revascularization processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Nitric oxide as a signal in blood vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

The role of nitric oxide in tumour progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

The L-arginine-nitric oxide pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Nitric oxide synthases: regulation and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Diminished NO release in chronic hypoxic human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Hypoxic repression of endothelial nitric-oxide synthase transcription is coupled with eviction of promoter histones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Hypoxia-induced upregulation of eNOS gene expression is redox-sensitive: a comparison between hypoxia and inhibitors of cell metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Upregulation of eNOS in pregnant ovine uterine arteries by chronic hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Decreased endothelial nitric-oxide synthase (eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Flow-regulated endothelial S1P receptor-1 signaling sustains vascular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Sphingosine-1-phosphate: a novel nonhypoxic activator of hypoxia-inducible factor-1 in vascular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

S-nitrosylation of beta-catenin by eNOS-derived NO promotes VEGF-induced endothelial cell permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Regulation of HIF-1alpha stability through S-nitrosylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

S-nitrosothiols signal hypoxia-mimetic vascular pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Endogenous S-nitrosothiols protect against myocardial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Nitric oxide modulates oxygen sensing by hypoxia-inducible factor 1-dependent induction of prolyl hydroxylase 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

The interplay between macrophages and angiogenesis in development, tissue injury and regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Monocyte and macrophage heterogeneity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Hypoxia-inducible factor-2α regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Opposing roles for HIF-1α and HIF-2α in the regulation of angiogenesis by mononuclear phagocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Stabilization of HIF-2α induces sVEGFR-1 production from tumor-associated macrophages and decreases tumor growth in a murine melanoma model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Endothelial cell HIF-1α and HIF-2α differentially regulate metastatic success

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Hypoxia inducible factor-2alpha in cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Mitochondria as signaling organelles in the vascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Nitric oxide, cytochrome C oxidase, and the cellular response to hypoxia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Regulation of hypoxia-inducible factor-1alpha by nitric oxide through mitochondria-dependent and -independent pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

Redox signaling in vascular angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

NADPH oxidases as regulators of tumor angiogenesis: current and emerging concepts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2013.02.010

10.1016/J.YEXCR.2013.02.010

7 January 2021

Identifiers

DOI

1 reference

28 August 2017

1 reference

PubMed ID

23485765